Center for Scientific Review; Notice of Closed Meeting, 79894 [2022-28183]
Download as PDF
<![CDATA[
ddrumheller on DSK6VXHR33PROD with NOTICES
79894
Federal Register / Vol. 87, No. 248 / Wednesday, December 28, 2022 / Notices
https://www.hhs.gov/paccarb and must
be completed by January 18, 2023 for
the January 24–25, 2023 Public Meeting.
Additional information about registering
for the meeting and providing public
comment can be obtained at https://
www.hhs.gov/paccarb on the Upcoming
Meetings page.
DATES: The meeting is scheduled to be
held on January 24–25, 2023, from 10
a.m. to 4 p.m. ET (times are tentative
and subject to change). The confirmed
times and agenda items for the meeting
will be posted on the website for the
PACCARB at https://www.hhs.gov/
paccarb when this information becomes
available. Pre-registration for attending
the meeting is strongly suggested and
should be completed no later than
January 18, 2023.
ADDRESSES: Instructions regarding
attending this meeting virtually will be
posted at least one week prior to the
meeting at: https://www.hhs.gov/
paccarb.
FOR FURTHER INFORMATION CONTACT:
Jomana Musmar, M.S., Ph.D.,
Designated Federal Officer, Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of
the Assistant Secretary for Health, U.S.
Department of Health and Human
Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202–746–
1512; Email: CARB@hhs.gov.
SUPPLEMENTARY INFORMATION: The
Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB), established by Executive
Order 13676, is continued by section
505 of Public Law 116–22, the
Pandemic and All-Hazards
Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and
duties of the Advisory Council are
governed by the provisions of the
Federal Advisory Committee Act
(FACA), Public Law 92–463, as
amended (5 U.S.C. app.), which sets
forth standards for the formation and
use of Federal advisory committees.
The PACCARB shall advise and
provide information and
recommendations to the Secretary
regarding programs and policies
intended to reduce or combat antibioticresistant bacteria that may present a
public health threat and improve
capabilities to prevent, diagnose,
mitigate, or treat such resistance. The
PACCARB shall function solely for
advisory purposes.
Such advice, information, and
recommendations may be related to
improving: the effectiveness of
antibiotics; research and advanced
research on, and the development of,
improved and innovative methods for
VerDate Sep<11>2014
18:26 Dec 27, 2022
Jkt 259001
combating or reducing antibiotic
resistance, including new treatments,
rapid point-of-care diagnostics,
alternatives to antibiotics, including
alternatives to animal antibiotics, and
antimicrobial stewardship activities;
surveillance of antibiotic-resistant
bacterial infections, including publicly
available and up-to-date information on
resistance to antibiotics; education for
health care providers and the public
with respect to up-to-date information
on antibiotic resistance and ways to
reduce or combat such resistance to
antibiotics related to humans and
animals; methods to prevent or reduce
the transmission of antibiotic-resistant
bacterial infections; including
stewardship programs; and coordination
with respect to international efforts in
order to inform and advance the United
States capabilities to combat antibiotic
resistance.
The January 24–25, 2023, public
meeting will continue the PACCARB’s
discussion about how antimicrobial
resistance can be integrated into existing
national pandemic preparedness plans.
The focus of the meeting will be
exploring the challenges regarding
communicating science and
antimicrobial resistance during a
pandemic, as well as exploring how to
address equity and vulnerable
populations in these plans. The meeting
agenda will be posted on the PACCARB
website at https://www.hhs.gov/paccarb
when it has been finalized. All agenda
items are tentative and subject to
change. Instructions regarding attending
the meeting virtually will be posted at
least one week prior to the meeting at:
https://www.hhs.gov/paccarb.
Members of the public will have the
opportunity to provide comments live
during the January meeting by preregistering online at https://
www.hhs.gov/paccarb. Pre-registration
is required for participation in this
session with limited spots available.
Written public comments can also be
emailed to CARB@hhs.gov by midnight
January 18, 2023 and should be limited
to no more than one page. All public
comments received prior to January 18,
2022, will be provided to the PACCARB
members. Additionally, companies and/
or organizations involved in combating
antibiotic resistance have an
opportunity to present their work to
members of the PACCARB live during
an Innovation Spotlight. Pre-registration
is required for participation, with
limited spots available. All information
regarding this session can also be found
online at https://www.hhs.gov/paccarb.
PO 00000
Frm 00046
Fmt 4703
Sfmt 9990
Dated: November 22, 2022.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant
Secretary for Health.
[FR Doc. 2022–28217 Filed 12–27–22; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Aging and
cognitive decline.
Date: January 3, 2023.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joanna Szczepanik, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 1000D,
Bethesda, MD 20892, (301) 827–2242
szczepaj@csr.nih.gov
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: December 21, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–28183 Filed 12–27–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 87, Number 248 (Wednesday, December 28, 2022)]
[Notices]
[Page 79894]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28183]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Aging and cognitive decline.
Date: January 3, 2023.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joanna Szczepanik, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Room 1000D, Bethesda, MD 20892, (301) 827-2242
[email protected]
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: December 21, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-28183 Filed 12-27-22; 8:45 am]
BILLING CODE 4140-01-P
